Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)Debora Basile, M. Svrcek, Franck Pagès et al.|Annals of Oncology|2022Cited by 44
388MO Tumor budding, an important prognostic factor in stage III colon cancer patients treated with oxaliplatin-based chemotherapyDebora Basile, Magali Svrcek, Chloé Broudin et al.|Annals of Oncology|2021Cited by 0